Over $200 million in ill-gotten profits in a decade long crime spree has cost Teva Pharmaceutical Industries Ltd. a more than half a billion-dollar settlement with the Securities and Exchange Commission and the Department of Justice – a sum that appears to be the largest ever for a pharmaceutical company in violating the Foreign Corrupt Practices Act (FCPA).
An SEC investigation found that the generic drugs giant had bribed government officials in the Ukraine, Russia and Mexico to sell and promote its products, reeling in illegal profits of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?